Advertisement
Advertisement
PGNY
Progyny, Inc. Common Stock
23.25
USDSponsored
+0.38
+1.66%
May 15, 15:59 UTC -4
Closed
After-Market
23.21
-0.04
-0.17%
PGNY Earnings Reports
Positive Surprise Ratio
PGNY beat 20 of 27 last estimates.
74%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$355.90M
/$0.31
Implied change from Q1 26 (Revenue/ EPS)
+8.34%
/+10.71%
Implied change from Q2 25 (Revenue/ EPS)
+6.92%
/+63.16%
Progyny, Inc. Common Stock earnings per share and revenue
On May 07, 2026, PGNY reported earnings of 0.28 USD per share (EPS) for Q1 26, missing the estimate of 0.30 USD, resulting in a -4.89% surprise. Revenue reached 328.50 million, compared to an expected 333.04 million, with a -1.36% difference. The market reacted with a +23.80% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 0.31 USD, with revenue projected to reach 355.90 million USD, implying an increase of 10.71% EPS, and increase of 8.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-Surprise
-
COMPASS Pathways Plc - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.30
Surprise
+22.20%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.09
Actual
$0.11
Surprise
+11.11%
Forward Industries, Inc. Common Stock
Report Date
May 14, 2026 For Q2 26
Estimate
-$0.03
Actual
$0.04
Surprise
+230.72%
Shoulder Innovations, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.42
Actual
-$0.41
Surprise
+3.10%
Park Dental Partners, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
$0.20
Actual
$0.44
Surprise
+115.69%
SeaStar Medical Holding Corporation Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.83
Actual
-$0.90
Surprise
-8.00%
Lifeward Ltd. Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.28
Actual
-$3.63
Surprise
-183.57%
Aclarion, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.58
Actual
-$1.34
Surprise
+15.24%
Synergy CHC Corp. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.03
Actual
-$0.23
Surprise
-744.26%
FAQ
What were Progyny, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Progyny, Inc. Common Stock reported EPS of $0.28, missing estimates by -4.89%, and revenue of $328.50M, -1.36% below expectations.
How did the market react to Progyny, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 23.8%, changed from $19.16 before the earnings release to $23.72 the day after.
When is Progyny, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Progyny, Inc. Common Stock's next earnings report?
Based on 10
analysts, Progyny, Inc. Common Stock is expected to report EPS of $0.31 and revenue of $355.90M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement